Vitiligo worsened following the second dose of mRNA SARS-CoV-2 vaccine.

Caroppo, Francesca; Deotto, Maria Ludovica; Tartaglia, Jacopo; Belloni Fortina, Anna

Caroppo, Francesca; Deotto, Maria Ludovica; Tartaglia, Jacopo; Belloni Fortina, Anna.

Caroppo F; Dermatology Unit - Department of Medicine DIMED, University of Padova, Padova, Italy.
Deotto ML; Dermatology Unit - Department of Medicine DIMED, University of Padova, Padova, Italy.
Tartaglia J; Dermatology Unit - Department of Medicine DIMED, University of Padova, Padova, Italy.
Belloni Fortina A; Dermatology Unit - Department of Medicine DIMED, University of Padova, Padova, Italy.

Dermatol Ther ; 35(6): e15434, 2022 06.

Article in English | MEDLINE | ID: covidwho-1735907

Subject(s)

COVID-19 Vaccines; COVID-19; Vitiligo; COVID-19/prevention & control; COVID-19 Vaccines/adverse effects; Humans; SARS-CoV-2; Vitiligo/chemically induced; mRNA Vaccines/adverse effects

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vitiligo / COVID-19 Vaccines / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Dermatol Ther Journal subject: Dermatology Year: 2022 Document Type: Article Affiliation country: Dth.15434

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google